» Articles » PMID: 8100480

P53 Gene Mutations and 17p Allelic Deletions in Hepatocellular Carcinoma from Japan

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 1993 Jul 15
PMID 8100480
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: p53 gene mutations at codon 249 have been reported in hepatocellular carcinoma (HCC) from China and South Africa, a phenomenon shown to be closely associated with food contamination by aflatoxin. There have been few reports, however, in regard to p53 gene mutations in HCC from other geographic areas.

Methods: The authors analyzed 20 HCC from Japan for alteration of the p53 gene by restriction fragment length polymorphisms and for nucleic acid mutations by polymerase chain reaction with direct sequencing.

Results: Alterations associated with the p53 gene were found in 6 of 20 HCC (30%). Allelic loss of chromosome 17p occurred in 5 of 14 informative (heterozygous) cases (36%). Mutations in the p53 gene were detected in three cases (15%), at codons 176 (exon 5), 236 (exon 7), and 294 (exon 8). These cases were different from the HCC cases from China and South Africa, where point mutations in the p53 gene were reported at the same codon 249 in half of the cases and where aflatoxin food contamination and hepatitis B virus infection are recognized risk factors of HCC. No p53 gene alterations were found in smaller HCC (< 3 cm) or at earlier stages.

Conclusions: In Japan, p53 gene alterations seem to be a late event in the progression of hepatocarcinogenesis, which is often associated with persistent infection by the hepatitis C or B virus, but not usually with exposure to aflatoxin.

Citing Articles

MDM2: current research status and prospects of tumor treatment.

Yao Y, Zhang Q, Li Z, Zhang H Cancer Cell Int. 2024; 24(1):170.

PMID: 38741108 PMC: 11092046. DOI: 10.1186/s12935-024-03356-8.


Cell Differentiation Trajectory in Liver Cirrhosis Predicts Hepatocellular Carcinoma Prognosis and Reveals Potential Biomarkers for Progression of Liver Cirrhosis to Hepatocellular Carcinoma.

He Z, Peng C, Li T, Li J Front Genet. 2022; 13:858905.

PMID: 35360852 PMC: 8960263. DOI: 10.3389/fgene.2022.858905.


Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC).

Zhao P, Malik S, Xing S Front Oncol. 2021; 11:677926.

PMID: 34336665 PMC: 8320331. DOI: 10.3389/fonc.2021.677926.


Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review.

Kanda T, Goto T, Hirotsu Y, Moriyama M, Omata M Int J Mol Sci. 2019; 20(6).

PMID: 30889843 PMC: 6470669. DOI: 10.3390/ijms20061358.


RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.

Ye J, Liang R, Bai T, Lin Y, Mai R, Wei M J Exp Clin Cancer Res. 2018; 37(1):212.

PMID: 30176896 PMC: 6122209. DOI: 10.1186/s13046-018-0852-x.